Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications

Ji Hoon Kim; Chung Oui Hong; Yun Chang Koo; Su Jung Kim; Kwang Won Lee

doi:10.1248/bpb.34.1702

Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications

Ji Hoon Kim, Chung Oui Hong, Yun Chang Koo, Su Jung Kim, Kwang Won Lee

Department of Biotechnology

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Abstract

Terminalia chebula has been widely used in India as a folk medicine. This study investigated the in vivo antihyperglycemia and anti-diabetic complication effects of the EtOAc-soluble portion of ethanolic extract of T. chebula fruit (EETC) containing 29.4% chebulic acid. Rats were divided into non-diabetic, untreated diabetic and diabetic groups. Streptozotocin (40 mg/kg body weight (BW))-induced diabetic rats were orally administered the aminoguanidine (100 mg/kg BW), high dose (500 mg/kg BW; HEETC) and low dose (100 mg/kg BW; LEETC) for 13 weeks. HEETC administration reduced the levels of blood glucose and serum lipids, decreased malondialdehyde concentrations of serum and thoracic aorta in diabetic rats, and significantly improved serum biochemical values and the pathomorphological changes of the liver and kidney in diabetic rats. Also, HEETC decreased the advanced glycation end products (AGEs) distribution in testis seminiferous tubules. Therefore, HEETC has a merit to be a potent candidate to control glycemic and diabetic complications.

Original language	English
Pages (from-to)	1702-1709
Number of pages	8
Journal	Biological and Pharmaceutical Bulletin
Volume	34
Issue number	11
DOIs	https://doi.org/10.1248/bpb.34.1702
Publication status	Published - 2011 Nov

Keywords

Advanced glycation end product
Glutathione
Lipid peroxidation
Streptozotocin
Terminalia chebula
Testicular dysfunction

ASJC Scopus subject areas

Pharmacology
Pharmaceutical Science

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1248/bpb.34.1702

Cite this

Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications. / Kim, Ji Hoon; Hong, Chung Oui; Koo, Yun Chang et al.
In: Biological and Pharmaceutical Bulletin, Vol. 34, No. 11, 11.2011, p. 1702-1709.

Research output: Contribution to journal › Article › peer-review

@article{a8f7dcb4dd5b40e3a51748c059781d3a,

title = "Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications",

abstract = "Terminalia chebula has been widely used in India as a folk medicine. This study investigated the in vivo antihyperglycemia and anti-diabetic complication effects of the EtOAc-soluble portion of ethanolic extract of T. chebula fruit (EETC) containing 29.4% chebulic acid. Rats were divided into non-diabetic, untreated diabetic and diabetic groups. Streptozotocin (40 mg/kg body weight (BW))-induced diabetic rats were orally administered the aminoguanidine (100 mg/kg BW), high dose (500 mg/kg BW; HEETC) and low dose (100 mg/kg BW; LEETC) for 13 weeks. HEETC administration reduced the levels of blood glucose and serum lipids, decreased malondialdehyde concentrations of serum and thoracic aorta in diabetic rats, and significantly improved serum biochemical values and the pathomorphological changes of the liver and kidney in diabetic rats. Also, HEETC decreased the advanced glycation end products (AGEs) distribution in testis seminiferous tubules. Therefore, HEETC has a merit to be a potent candidate to control glycemic and diabetic complications.",

keywords = "Advanced glycation end product, Glutathione, Lipid peroxidation, Streptozotocin, Terminalia chebula, Testicular dysfunction",

author = "Kim, {Ji Hoon} and Hong, {Chung Oui} and Koo, {Yun Chang} and Kim, {Su Jung} and Lee, {Kwang Won}",

year = "2011",

month = nov,

doi = "10.1248/bpb.34.1702",

language = "English",

volume = "34",

pages = "1702--1709",

journal = "Biological and Pharmaceutical Bulletin",

issn = "0918-6158",

publisher = "Pharmaceutical Society of Japan",

number = "11",

}

TY - JOUR

T1 - Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications

AU - Kim, Ji Hoon

AU - Hong, Chung Oui

AU - Koo, Yun Chang

AU - Kim, Su Jung

AU - Lee, Kwang Won

PY - 2011/11

Y1 - 2011/11

N2 - Terminalia chebula has been widely used in India as a folk medicine. This study investigated the in vivo antihyperglycemia and anti-diabetic complication effects of the EtOAc-soluble portion of ethanolic extract of T. chebula fruit (EETC) containing 29.4% chebulic acid. Rats were divided into non-diabetic, untreated diabetic and diabetic groups. Streptozotocin (40 mg/kg body weight (BW))-induced diabetic rats were orally administered the aminoguanidine (100 mg/kg BW), high dose (500 mg/kg BW; HEETC) and low dose (100 mg/kg BW; LEETC) for 13 weeks. HEETC administration reduced the levels of blood glucose and serum lipids, decreased malondialdehyde concentrations of serum and thoracic aorta in diabetic rats, and significantly improved serum biochemical values and the pathomorphological changes of the liver and kidney in diabetic rats. Also, HEETC decreased the advanced glycation end products (AGEs) distribution in testis seminiferous tubules. Therefore, HEETC has a merit to be a potent candidate to control glycemic and diabetic complications.

AB - Terminalia chebula has been widely used in India as a folk medicine. This study investigated the in vivo antihyperglycemia and anti-diabetic complication effects of the EtOAc-soluble portion of ethanolic extract of T. chebula fruit (EETC) containing 29.4% chebulic acid. Rats were divided into non-diabetic, untreated diabetic and diabetic groups. Streptozotocin (40 mg/kg body weight (BW))-induced diabetic rats were orally administered the aminoguanidine (100 mg/kg BW), high dose (500 mg/kg BW; HEETC) and low dose (100 mg/kg BW; LEETC) for 13 weeks. HEETC administration reduced the levels of blood glucose and serum lipids, decreased malondialdehyde concentrations of serum and thoracic aorta in diabetic rats, and significantly improved serum biochemical values and the pathomorphological changes of the liver and kidney in diabetic rats. Also, HEETC decreased the advanced glycation end products (AGEs) distribution in testis seminiferous tubules. Therefore, HEETC has a merit to be a potent candidate to control glycemic and diabetic complications.

KW - Advanced glycation end product

KW - Glutathione

KW - Lipid peroxidation

KW - Streptozotocin

KW - Terminalia chebula

KW - Testicular dysfunction

UR - http://www.scopus.com/inward/record.url?scp=81455128723&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81455128723&partnerID=8YFLogxK

U2 - 10.1248/bpb.34.1702

DO - 10.1248/bpb.34.1702

M3 - Article

C2 - 22040883

AN - SCOPUS:81455128723

SN - 0918-6158

VL - 34

SP - 1702

EP - 1709

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

IS - 11

ER -

Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this